ABBOTT MEDICAL NORWAY AS: årsregnskap 2024 vs 2023
Grew 14% on revenue
approved 2025-06-30; registry 2025-07-05; journal 2025 629137
Summary
What changed
Comparing Årsregnskap 2024 with 2023 for ABBOTT MEDICAL NORWAY AS. Revenue 165.88m NOK → 188.54m NOK (+13.7%). Net result +4.36m NOK → +5.03m NOK. Equity 29.17m NOK → 34.19m NOK.
On the constructive side: revenue rose; operating result improved; net result improved. Pressures included: cash fell.
Also worth watching: payroll increased; cogs moved; headcount (årsverk) changed. All figures are taken from the published annual accounts for ABBOTT MEDICAL NORWAY AS.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 165.88m NOK to 188.54m NOK (+13.7% YoY). Calculated
-
↑
Operating result improved
Operating result +5.35m NOK → +5.67m NOK (op. margin 3.2% → 3.0%). Calculated
-
↑
Net result improved
Net result +4.36m NOK → +5.03m NOK (net margin 2.6% → 2.7%). Calculated
-
↑
Equity strengthened
Book equity 29.17m NOK → 34.19m NOK (equity ratio 50.1% → 46.1%). Calculated
What deteriorated
-
↓
Cash fell
Bank deposits 15.05m NOK → 14.66m NOK (-2.6% YoY). Calculated
Things to notice
-
·
Payroll increased
Salary cost 19.24m NOK → 20.04m NOK (12% → 11% of revenue). Calculated
-
·
COGS moved
COGS / varekostnad 3.13bn NOK → 3.15bn NOK (+0.7% YoY). Calculated
-
·
Headcount (årsverk) changed
Reported FTEs 16 → 15. Reported fact